论文部分内容阅读
近年来,肿瘤患者数量不断增多,临床对肿瘤患者实施放疗、化疗的过程中,除了有效杀死疾病细胞外,也无法避免的会对正常身体机能的细胞造成不利影响,由此给很多患者都带来了较强的副作用,包括呕吐、脱发、头晕等等,这些病痛对患者而言,是难以言喻的。从临床的角度来分析,针对肿瘤患者在开展治疗的过程中,可适当的运用一定的细胞保护剂,对患者的身体正常细胞实施保护作用,一方面不影响放疗、化疗的正常作用,另一方面充分减少患者的不良反应,达到有效治疗、强效保护的效果。细胞保护剂氨磷汀是临床上比较常用的一类药物,具有深度研发价值。
In recent years, the increasing number of cancer patients, clinical cancer patients during the implementation of radiotherapy and chemotherapy, in addition to effectively kill the disease cells, but also can not be avoided will have an adverse effect on normal bodily functions of cells, thus giving many patients Brought a strong side effects, including vomiting, hair loss, dizziness, etc., these illnesses for the patient, is hard to explain. From the clinical point of view, for the treatment of cancer patients in the process of treatment, may be appropriate to use a certain cytoprotective agent to protect the patient’s normal cells, on the one hand does not affect the normal role of radiotherapy and chemotherapy, the other To fully reduce the side effects of patients, to achieve effective treatment, effective protection effect. Cytoprotein amifostine is a more commonly used clinical class of drugs, with a deep research and development value.